Opportunities and risks of genetically modified food

In its new publication, the Senate commission deals with issues concerning the objectives, application and legal framework of green genetic engineering. It comments on conceivable risks resulting from the cultivation and consumption of genetically modified plants or food and refers to safety precautions to protect the consumer. The statement focuses on food from transgenic plants. Animal food is to be dealt with at a later point in a separate publication.

The statement has been coordinated with the Senate commission on food safety and is to appear as a bilingual publication in German and English.

For thousands of years, human beings have been cultivating useful plants with the aim of achieving higher and more predictable yields with certain quality and processing qualities. Here, genetic methods are particularly beneficial, for with their aid, hereditary matter from organisms of different species can also be transferred to certain breeds to encourage the development of desired properties. In comparison with conventional varieties, transgenic useful plants display considerable advantages. They are resistant to pests and diseases, have an improved herbicide tolerance and also thrive in unfavourable environmental conditions. And food with physiologically important contents can be produced more efficiently with transgenic micro-organisms. Micro-organisms of this kind are employed as producers of metabolic products and enzymes and as fermentation aids.

Biologically modified food has to fulfil the same safety requirements as traditional products. So potential risks have to be identified and assessed at an early stage. In this context, the Senate commission recommends sticking to the tried-and-tested regulations on tests stipulated in the law on genetic engineering and food and urging for a uniform implementation of national and European guidelines supplemented by provisions on seed for animal feed and food. Only with the approval of the public at l

Contact: Dr. Eva-Maria Streier
Deutsche Forschungsgemeinschaft

Page: 1 2

Related biology news :

1. Human health risks in space flight focus of research internships
2. Articles on forest fire risks published in BioScience
3. Many physicians misperceive radiation risks to developing fetuses from X-rays and CT scans
4. Health risks of phthalates
5. Stem-cell therapy could have benefits and risks for heart-attack PTs
6. Bacteria lingering in body may pose future food poisoning risks, Stanford study finds
7. OHSU team discovers compound that lacks estrogens risks
8. Five studies look at risks of differing particulate matter, including exposures on 9/11
9. High-density storage of nuclear waste heightens terrorism risks
10. Stanford researchers develop gene therapy technique that sharply cuts risks
11. National study halted since health risks exceed benefits in postmenopausal women on estrogen

Post Your Comments:

(Date:8/21/2020)... ... August 19, 2020 , ... ... SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty years. Together ... book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary ... Both Roche and J&J have annual Research and Development spending in excess of ...
(Date:8/7/2020)... , ... August 06, 2020 , ... ... participate in the prestigious National STEM Scholar Program, a unique professional development program ... and project support for middle school science teachers nationwide. , Created in partnership ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 16, 2020 , ... After ... begins. The completion of a great surgery is only the beginning of a successful ... the research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
Breaking Biology Technology:
Cached News: